Award recordCONTRACT

ARIAD PHARMACEUTICALS, INC.

PIID VA26015F0311· VHA· 260-NETWORK CONTRACT OFFICE 20· 6505 · DRUGS AND BIOLOGICALS· FY2015· $69,248 net obligations· UEI EVMMLCKBZS47· MA

Description

DRUG PONATINIB 45MG

First action · last action
2014-10-29 · 2015-10-30
Transactions
3
First transaction's obligation
$87,251
Base + all options value (sum of deltas)
$69,248
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D3005E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$87,251$0Base award · 2014-10-29 · this action $87,251 · running total $87,251Modification P00001 · 2015-07-30 · this action -$15,000 · running total $72,251Modification P00002 · 2015-10-30 · this action -$3,003 · running total $69,248
  • Base2014-10-29+$87,251= $87,251
  • Mod P000012015-07-30-$15,000= $72,251
  • Mod P000022015-10-30-$3,003= $69,248
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-29+$87,251$87,251DRUG PONATINIB 45MG
Mod P00001· FUNDING ONLY ACTION2015-07-30−$15,000$72,251DRUG PONATINIB 45MG
Mod P00002· FUNDING ONLY ACTION2015-10-30−$3,003$69,248DRUG PONATINIB 45MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EVMMLCKBZS47)

AwardOffice · PSC / listingNet obligationsFY
36C25219F0494252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919N0606249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$23,004FY2019
36C25219F0450252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919F0373249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$11,502FY2019
36C24519F0682245-NETWORK CONTRACT OFFICE 5 (36C245) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$0FY2019
36C25219F0412252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26016F0697LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20$6,829FY2016
VA26016F0673UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20$8,906FY2016
VA26016J0622SANOFI VACCINES US INC.260-NETWORK CONTRACT OFFICE 20$396,690FY2016
VA26016J0621SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$176,120FY2016
VA26016J0613SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$74,617FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26015F0311_3600_V797D3005E_3600 · retrieved 2026-09-26.